Brace vs Stimulator for Foot Drop

What Works

1. Confirm whether the lesion is upper or lower motor neuron, before any device conversation MODERATE

This is a screening decision, not a treatment, and it belongs first because it decides which options exist. A stimulator lifts the foot by sending a pulse to the common peroneal nerve. Where that nerve is the injury, there is no mechanism.

Evidence: MODERATE, and it is regulatory plus mechanistic rather than trial-based. Stimulation is NICE-approved for foot drop of upper motor neuron origin, and in the one series reporting non-response, 12 of 33 referred patients got no benefit, attributed by the authors to the degree of peripheral neuropathy (Goodison 2022, PMID 35028266).

2. Offer either a brace or a stimulator for foot drop of central origin STRONG

Worn for all walking at home and in the community, which is how every trial used them.

Evidence: STRONG. A clinical practice guideline built on 122 studies grades the evidence strong for both devices on walking speed, mobility and dynamic balance, and finds direct comparisons show no superiority either way (Johnston 2021, PMID 33675603). Head-to-head pooled walking speed difference is 0.00 m/s (95% CI -0.06 to 0.05) across 11 trials and 1,135 people (Nascimento 2020, PMID 33120054). The largest trial, 495 people randomised across 30 centres, found the stimulator non-inferior on every primary endpoint at 6 and 12 months (Bethoux 2014 and 2015, PMID 24526708, PMID 25653225).

3. Do not use either device to reduce calf tightness or spasticity STRONG

Evidence: STRONG. Stated directly as a negative recommendation in the guideline (Johnston 2021, PMID 33675603).

4. Choose between them on effort, obstacles, cost and acceptability, not expected walking speed MODERATE

Evidence: MODERATE. The stimulator reduced the energy cost of walking and was preferred across 6 trials and 820 people (Dunning 2015, PMID 26035725), lowered perceived effort in a 20-person crossover in multiple sclerosis (Khurana 2017, PMID 27680426), scored higher on satisfaction in a 197-person trial (Kluding 2013, PMID 23640829), and scored higher on confidence, adaptability and self-esteem in multiple sclerosis (Renfrew 2019, PMID 30974955). Every one of those endpoints is subjective and no trial in this topic blinded anyone, which is exactly why this is moderate and not strong.

5. Reassess rather than treating the first device as permanent MODERATE

Evidence: MODERATE. Recommended explicitly in the guideline, on the grounds that the most suitable device for a person can change and gains are possible at any stage after stroke (Johnston 2021, PMID 33675603). No trial tested a review interval, so none is prescribed here.

Tier 3 — Emerging options

Implanted nerve stimulation for chronic stroke users who need adaptable walking. EMERGING Better obstacle avoidance than a brace in 22 implanted patients followed to 26 or 52 weeks (Berenpas 2019, PMID 31071538), and more accurate, less mentally demanding target stepping with stimulation on versus off in 13 patients (Berenpas 2022, PMID 35512467). Small samples, surgical, and never compared against the ordinary external stimulator.

A flexible rather than rigid brace where endurance is the goal in multiple sclerosis. EMERGING Six-minute walk distance favoured flexible designs by 45.82 m (95% CI 26.93 to 64.71), inside a review whose main analysis found no significant brace effect on any core walking measure (Mosharaf 2026, PMID 42080501).

Exercise Prescription

There is no exercise programme on this page, and that is the honest output rather than a gap

Not one of the 25 studies behind this page prescribed, progressed or measured an exercise, stretch or hands-on treatment as part of choosing or using either device. The only exercise dose recorded anywhere in this literature is 8 physical therapy sessions given to both arms of one trial during its first 6 weeks (Kluding 2013, PMID 23640829), which by design cannot tell you what the exercise contributed. Writing a sets-and-reps table here would mean inventing one.

What the evidence does support is a wear-and-review plan.

Wear it for all walking, not just for appointments. That is how every trial used both devices. The effect is there on day one.
Do the on/off timed walk at fitting, and again if anything changes.
Check your skin daily, under the brace or at the pads, especially anywhere sensation is reduced.
Keep the ankle moving so it does not stiffen into a pointed-down position, which would stop either device working.
Book a review. The guideline specifically says the best device for a person can change.

What Doesn't Work

Prescribing either device to reduce spasticity. The guideline advises against it directly. It persists because tightness and foot drop turn up together and the device visibly changes the foot position.
Telling someone the device will stop them falling. Long-term users fell 2.50 (brace) and 2.77 (stimulator) times more often than non-users during trip-like tests, and taking the devices off changed nothing (Nevisipour 2022, PMID 34847412). The devices reduce how often you catch your toe. They do nothing to help you recover once a trip is already underway. Part of that raised fall rate reflects who gets given a device in the first place, which is exactly why the honest sentence is "this reduces toe catching" and not "this will stop you falling".
Quoting stroke or multiple sclerosis figures to someone with a damaged leg nerve. The most available error in this topic.
Claiming either device speeds nerve healing. No study here measured nerve recovery at all.

Cinematic study of an ankle and foot in dramatic side light against deep shadow

Red Flags

Refer, do not fit a device

New, rapidly progressive or worsening weakness. May indicate an evolving compressive, inflammatory or demyelinating lesion.
Foot drop in both legs. Raises suspicion of a spinal, systemic or inherited cause rather than a single damaged nerve.
Any change in bladder or bowel control, or numbness around the saddle area. Possible cauda equina compromise.
Foot drop with severe back or leg pain, or following trauma. Possible nerve root compression, fracture or acute compressive lesion.
Broken skin under a brace, or a burn or persistent skin reaction at an electrode site. Device-related tissue damage, especially where sensation is reduced.

Refer to: GP or Neurology for new, progressive, bilateral or unexplained foot drop. A&E for suspected cauda equina. Orthotics for a device causing skin breakdown.

These come from standard neurological screening, not from the device studies. The 25 studies behind this page contain no red-flag content at all, and saying so is more useful than implying they do.

Cinematic anatomical study of the lower leg and ankle in dramatic low light

Return to Training

Nothing about foot drop or either device restricts strength training. The only sensible modification is to reactive footwork on uneven ground, because neither device helps you catch yourself once a trip has begun.

Underlying cause identified, and upper versus lower motor neuron status established
Red flags screened and clear
Device fitted, tolerated for a full day, skin checked with no breakdown
On/off timed ten-metre walk performed and recorded
Walking is not slower with the device than without it
You can state what the device does and does not do, specifically that it reduces toe catching and is not a falls treatment
Review appointment booked

At your next appointment, ask to walk ten metres timed with the device on, then ten metres timed with it off, in the same session.

Every study here compared groups. None of them tested whether a device suits an individual, and the one study that split people by walking speed found the two halves moving in opposite directions. This one comparison is the only thing that answers the question about you.

Takes about five minutes. No equipment beyond a stopwatch.

The Verdict

A brace and a stimulator work equally well. Ask which nerve is damaged before choosing.

A brace is a splint and a stimulator is a doorbell. The splint holds the foot up mechanically, so it works no matter what is broken further up the wire. The doorbell only rings if the wire still carries current. That is why the two devices tie in people whose wiring is intact, and why only one of them is an option when the wire itself is the injury.

What this actually is: two completely different devices that fix the same problem, and across a clinical guideline built on 122 studies plus three separate reviews, neither one walks you faster than the other.
What most people get wrong: the stimulator works by zapping one specific nerve in your leg, so if that nerve is the thing that is damaged, it has nothing to work with.
The one change that matters: before you compare devices, find out whether your foot drop comes from the brain and spinal cord or from a damaged nerve in the leg, because that decides which options you actually have.

Best for

Adults with foot drop after a stroke, multiple sclerosis or cerebral palsy, who are walking and want to stop catching their toe.

Skip if

Your foot drop comes from a damaged nerve in the leg itself. No study has compared these devices in that situation, and the stimulator has nothing to stimulate.

Want the full evidence? Keep scrolling

Conviction

MODERATE-HIGH OVERALL Scored per claim, because the headline and the caveats do not share a grade.

In stroke, a brace and a stimulator are equivalent for walking speed	HIGH
In stroke, both devices beat no device	HIGH
Either device is a reasonable first choice in central-origin foot drop	HIGH
Neither should be used to reduce spasticity	HIGH
In multiple sclerosis, the two are equivalent	MODERATE
The stimulator is more efficient and better liked	MODERATE
In multiple sclerosis, braces improve walking speed at all	LOW
Device choice can be matched to an individual characteristic	LOW
Either device helps balance recovery once a trip has begun	LOW
Either device works in foot drop from a damaged leg nerve	NO DATA

What would change my mind — the two claims that matter

On the transfer gap. A randomised trial of at least 120 adults with confirmed foot drop from a damaged leg nerve, with baseline nerve conduction documented to confirm the nerve is still stimulable, allocated to brace versus stimulator versus brace plus progressive strengthening, followed 12 months with walking speed and independent walking as co-primary endpoints. A null result would be as useful as a positive one. Nothing resembling this exists.

On individual allocation. A randomised trial of at least 200 people after stroke comparing allocation by a pre-specified selection rule against arbitrary allocation, with six-minute walk distance at 12 months as the primary endpoint. That would turn nine years of demonstrated group equivalence into an actual clinical decision.

Next step

Do not want to guess which device to ask for next time? The Verdict sends one evidence-graded protocol a week, free.

Join The Verdict — free

The Full Picture — Anatomy, Diagnosis & Evidence

What's Actually Going On

Foot drop means the muscles that lift the front of the foot are not firing properly during the swing phase of walking. The toe catches, so people compensate by hitching the hip, swinging the leg outward, or lifting the knee higher than normal.

The two devices attack it from opposite directions, and every useful difference between them follows from that.

A brace is a passive splint. It holds the ankle near neutral so the toe clears the floor. It works mechanically, which means it works whether or not any nerve or muscle below the knee still functions. The price of that reliability is that it restricts ankle movement.

A stimulator is an active device. It sends a timed electrical pulse to the common peroneal nerve during swing phase, contracting the person's own muscles to lift the foot. It restricts nothing.

Three things follow, and the third is the one that matters most. Because the stimulator leaves the ankle free, its advantage shows up in adaptable walking rather than steady walking, on obstacle courses and target stepping (Berenpas 2019, PMID 31071538; Berenpas 2022, PMID 35512467). Because it recruits the person's own muscle, it has a plausible route to a lasting effect, which the guideline notes as a suggestion while the meta-analysis built to test it found the two devices statistically equal (Prenton 2018, PMID 29227525). And because it works by stimulating one specific nerve, it needs that nerve to be intact.

Cinematic anatomical rendering of the lower leg musculature in deep shadow

How to Identify It

The clinically decisive question is not which device is better. It is whether the problem sits in the brain and spinal cord or in the nerve itself, because that determines which options exist at all.

Upper versus lower motor neuron screen (tone, reflexes, clonus, pattern of weakness) Sn: NO DATA | Sp: NO DATA Determines whether the stimulator has any mechanism. This literature reports no accuracy figures for it.
On/off timed ten-metre walk Sn: NO DATA | Sp: NO DATA The only assessment here that speaks about the individual rather than the group. It is the design Miller Renfrew 2018 used (PMID 31191925).
Graded and dated manual muscle test of the ankle lifters Sn: NO DATA | Sp: NO DATA Baseline severity and, for a nerve injury, the recovery marker. Every trial here measured walking, not strength.
Passive ankle range Sn: NO DATA | Sp: NO DATA A fixed pointed-down contracture changes what either device can achieve, because neither can hold a position the ankle cannot reach.

Every sensitivity and specificity cell on this page reads NO DATA, and the reason is worth printing: no study in this topic allocated anyone by a test result, so no test has ever been validated for this decision. Quoting a number here would mean inventing one.

Cinematic clinical study of an ankle being examined in dramatic low light

The Debate

Does a brace improve walking speed outside stroke?

The guideline and the stroke evidence: braces increase walking speed by 0.24 m/s versus no device (95% CI 0.06 to 0.41) after stroke, and the guideline grades the evidence strong (Nascimento 2020, PMID 33120054; Johnston 2021, PMID 33675603).

The newest multiple sclerosis evidence: no significant effect on walking speed, cadence, stride length or six-minute walk distance across 16 studies and 261 people. Ankle movement improved by 12.69 degrees, but the walking measures did not shift (Mosharaf 2026, PMID 42080501).

These are not in conflict. The guideline is a post-stroke document and never claimed to cover multiple sclerosis, which is progressive, relapsing, and comes with fatigue and heat sensitivity. Follow the guideline for stroke and the newer synthesis for multiple sclerosis. The practical consequence is that quoting stroke numbers to someone with multiple sclerosis overstates what is known.

Do these devices improve balance?

The guideline: strong evidence that both devices improve dynamic balance.

A 2022 biomechanics study: long-term users fell 2.50 and 2.77 times more than non-users under trip-like tests, and removing the devices changed nothing (Nevisipour 2022, PMID 34847412).

Two different things share the word balance. The guideline measures standing and clinical balance scales. The 2022 study measures what happens after a trip has already started, and finds the devices assist neither trunk control nor the second recovery step. Both are true. Prescribe for trip prevention and do not promise falls prevention.

Honest Limitations

The comparison was never run in the population that most often has foot drop in clinic

Every head-to-head study recruited people whose foot drop came from the brain or spinal cord. The inclusion criterion in one of the meta-analyses is literally foot drop "of central neurological origin". Meanwhile a great deal of clinical foot drop comes from a damaged nerve in the leg: compression at the knee, injury after hip or knee replacement, inherited neuropathy, drug-induced neuropathy. The stimulator works by stimulating precisely the nerve that is damaged in those cases. The equivalence result is real, and it does not transfer, and the direction of failure is predictable rather than merely unknown.

Not one study in this topic blinded its outcome assessment

You cannot blind someone to whether they are wearing a brace or receiving electrical stimulation, so this is a ceiling on the topic rather than a fixable flaw. It matters most for the endpoints that actually separate the two devices, which are preference, satisfaction and perceived effort. Those are exactly the measures most inflated by knowing which device you were given. One meta-analysis records that all 19 of its included studies rated weak for blinding, with none rated strong (Miller 2017, PMID 28088382).

Equivalence has been proven for groups and never tested for individuals

No trial has randomised people to a selection rule and asked whether matching the device to the person beats handing one out arbitrarily. The single study that split its sample by baseline walking speed found opposite effects in the two halves: the brace slowed the faster walkers, while the stimulator sped up only the slower ones (Miller Renfrew 2018, PMID 31191925). Averaging those two groups returns approximately zero, which is what every pooled result reports.

The Nuance

The simple version of this page is "they tie, so pick either". Three things that version misses.

First, a tie on walking speed is not a tie on everything. The stimulator consistently wins on the cost of walking and on how people feel about using it, and the brace is cheaper, simpler and needs no working nerve. Those are real differences; they are just not differences in how fast you walk.

Second, one study found a device making a group worse. The brace reduced walking speed in faster walkers with multiple sclerosis. That is a single-session finding and weaker evidence than the pooled results, but it is the only design in this topic capable of detecting it, and it is the strongest argument for testing the device on the individual rather than trusting the average.

Third, there is a surgical version. An implanted nerve stimulator outperformed a brace on obstacle avoidance in 22 patients (Berenpas 2019, PMID 31071538). It has never been compared against the ordinary external stimulator, and the tasks it was tested on were chosen because implanted stimulation should do well at them. Reasonable for a specific and uncommon patient. Not an upgrade path the evidence supports offering routinely.

Cinematic anatomical study contrasting nerve pathways of the lower limb in deep shadow

Sources

All sources are abstract-only. Every figure quoted on this page comes from the abstract of the paper it cites.

Johnston TE, Keller S, Denzer-Weiler C, et al. (2021). A Clinical Practice Guideline for the Use of Ankle-Foot Orthoses and Functional Electrical Stimulation Post-Stroke. J Neurol Phys Ther. PMID 33675603. Practice guideline, 122 included studies. The only guideline in this topic.
Nascimento LR, da Silva LA, Araújo Barcellos JVM, et al. (2020). Ankle-foot orthoses and continuous functional electrical stimulation improve walking speed after stroke. Physiotherapy. PMID 33120054. Meta-analysis, 11 trials, N=1,135. Head-to-head 0.00 m/s (95% CI -0.06 to 0.05).
Bethoux F, Rogers HL, Nolan KJ, et al. (2014). The effects of peroneal nerve functional electrical stimulation versus ankle-foot orthosis in patients with chronic stroke. Neurorehabil Neural Repair. PMID 24526708. RCT, 495 randomised, non-inferior at 6 months.
Bethoux F, Rogers HL, Nolan KJ, et al. (2015). Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis. Neurorehabil Neural Repair. PMID 25653225. RCT, 384 completed 12 months across 30 centres.
Prenton S, Hollands KL, Kenney LP (2016). Functional electrical stimulation versus ankle foot orthoses for foot-drop: A meta-analysis of orthotic effects. J Rehabil Med. PMID 27563700. Meta-analysis, N=815.
Prenton S, Hollands KL, Kenney LPJ, et al. (2018). Functional electrical stimulation and ankle foot orthoses provide equivalent therapeutic effects on foot drop. J Rehabil Med. PMID 29227525. Meta-analysis, N=464, walking speed p=0.46.
Goodison W, Baron F, Seary C, et al. (2022). Functional electrical stimulation to aid walking in patients with adrenomyeloneuropathy. JIMD Rep. PMID 35028266. Observational series, 21 treated; states the upper motor neuron approval scope.
Miller Renfrew L, Lord AC, McFadyen AK, et al. (2018). A comparison of the initial orthotic effects of functional electrical stimulation and ankle-foot orthoses. J Rehabil Assist Technol Eng. PMID 31191925. N=78; the brace slowed faster walkers.
Nevisipour M, Honeycutt CF (2022). Investigating the underlying biomechanical mechanisms leading to falls in long-term ankle-foot orthosis and functional electrical stimulator users. Gait Posture. PMID 34847412. N=42; device users fell more once a trip began.
Mosharaf M, Saberi S, Hillier S, et al. (2026). The effects of ankle-foot orthoses on the gait of people with multiple sclerosis. Disabil Rehabil. PMID 42080501. Systematic review and meta-analysis, 16 studies, N=261.
Miller L, McFadyen A, Lord AC, et al. (2017). Functional Electrical Stimulation for Foot Drop in Multiple Sclerosis. Arch Phys Med Rehabil. PMID 28088382. Meta-analysis, 19 studies, N=490; all rated weak for blinding.
Dunning K, O'Dell MW, Kluding P, et al. (2015). Peroneal Stimulation for Foot Drop After Stroke: A Systematic Review. Am J Phys Med Rehabil. PMID 26035725. 6 RCTs, N=820.
Kluding PM, Dunning K, O'Dell MW, et al. (2013). Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes. Stroke. PMID 23640829. FASTEST trial, N=197, single-blinded.
Renfrew LM, Paul L, McFadyen A, et al. (2019). The clinical- and cost-effectiveness of functional electrical stimulation and ankle-foot orthoses for foot drop in Multiple Sclerosis. Clin Rehabil. PMID 30974955. RCT, N=85, 12 months.
Khurana SR, Beranger AG, Felix ER (2017). Perceived Exertion Is Lower When Using a Functional Electrical Stimulation Neuroprosthesis. Am J Phys Med Rehabil. PMID 27680426. Crossover, N=20.
Berenpas F, Geurts AC, den Boer J, et al. (2019). Surplus value of implanted peroneal functional electrical stimulation over ankle-foot orthosis for gait adaptability. Gait Posture. PMID 31071538. N=22 implanted.
Berenpas F, Geurts A, Keijsers N, et al. (2022). Benefits of implanted peroneal functional electrical stimulation for continual gait adaptations. Hum Mov Sci. PMID 35512467. N=13.